Song et al. reported that high doses of IFN-γ stimulated the classic JAK/STAT pathway, while low doses of IFN-γ induced the activation of ICAM1-PI3K-Akt-Notch1 signaling in cancer cells, subsequently leading to increased expression of CD133 and cancer stemness [38]. The gene discussed is PROM1; the disease is cancer.